| Asking Price: |
Undisclosed |
| Revenue: |
$9,498
|
| Cash Flow: |
$1,091
|
The Company is a clinical-stage oncology company with a platform that combines biospectral impedance and AI/ML for point-of-care cancer detection. The lead product delivers rapid, in-procedure... More details »